Chinese vaccine maker CanSinoBIO said it found no cases of blood clots in people who received its vaccine, as similar jabs from AstraZeneca and Johnson & Johnson face scrutiny over the possible side effect.

The Global Times newspaper quoted the Tianjin-based pharmaceutical company as saying that it had not received any reports of blood clots in people who were inoculated with CanSinoBIO’s Covid-19 vaccine. (RT)